December 10, 2025
1 min read

FDA awards 1st national priority nod to USAntibiotics’ Augmentin XR

Roughly half a year after introducing the new regulatory pathway, the FDA has greenlit the first drug under its ultra-speedy—and controversial—Commissioner’s National Priority Voucher pilot review program. The inaugural approval under the program has gone to USAntibiotics and its domestically manufactured extended-release antibiotic Augmentin XR.

Leave a Reply

Your email address will not be published.

Previous Story

MAHA wants to tackle chronic diseases. This country had that idea decades ago

Next Story

Maternal Nutrition Supplement Market

Previous Story

MAHA wants to tackle chronic diseases. This country had that idea decades ago

Next Story

Maternal Nutrition Supplement Market

Latest from Blog

Study flags Karnataka’s child nutrition crisis

Child budget allocation: A government-backed study reveals Karnataka spent Rs 3.45 lakh crore on child programmes but underinvested in nutrition, leaving nearly one in five children suffering from wasting. Post Views: 2
Go toTop